相关实验视频

Updated: Jul 22, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

瘤免疫疗法的新希望:与巨细胞相关的"不要吃我"信号通路

Han Deng¹, Guan Wang¹, Shengyan Zhao¹

¹General Practice Ward/International Medical Center, General Practice Medical Center, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China School of Nursing, Sichuan University, Chengdu, Sichuan, China.

Frontiers in pharmacology

|July 24, 2023

概括

瘤细胞使用"不要吃我"通路,涉及CD47-SIRPα和CD24-Siglec10,以逃避免疫细胞. 用药物阻止这些信号可以增强巨细胞癌细胞清除以进行免疫治疗.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

瘤细胞通过免疫系统逃避免疫监测.
不要吃我,不要吃我.
信号通路,在许多癌症中积极表达.
像CD47和CD24这样的关键标志物在瘤细胞上高度表达,抑制了巨细胞细胞分裂.
CD47-SIRPα相互作用和CD24-Siglec10通路抑制了巨细胞吞癌细胞的发生.

研究的目的:

审查药物针对这些目标.
不要吃我,不要吃我.
信号通道. 信号通道.
总结大分子蛋白质和小分子药物的特征.
为开发针对CD47-SIRPα和CD24-Siglec10.0的新型免疫疗法提供见解.

主要方法:

对针对CD47-SIRPα和CD24-Siglec10通路的药物现有文献的审查.
药物特性的分析,包括大分子蛋白和小分子药物.
这些药物抑制免疫逃避的机制的概述.

主要成果:

这是一个很棒的节目,这是一个很棒的节目.
不要吃我,不要吃我.
这一途径涉及CD47-SIRPα和CD24-Siglec10相互作用.
阻止这些与药物的相互作用可以增强巨细胞介导的癌细胞清除.
大分子蛋白质和小分子药物都显示出阻断这些通路的潜力.

结论:

针对的目标是
不要吃我,不要吃我.
信号通路是一个有前途的癌症免疫治疗策略.
抑制CD47-SIRPα或CD24-Siglec10相互作用可以恢复巨细胞灭菌.
专注于这种途径的进一步药物开发可能会导致有效的癌症治疗.

关键词:

CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 抗体是一种抗体.小分子药物小分子药物不要吃我信号通道

更多相关视频

In Vitro Assay to Study Tumor-macrophage Interaction

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Phagocytosis of Apoptotic Cells

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...